Author

Jorge M. A. Oliveira

Observed names: J. Oliveira, J.M.A. Oliveira, Jorge M A Oliveira, Jorge M. A. Oliveira A, Jorge M.A. Oliveira, Jorge MA Oliveira, Jorge Miguel Ascenção Oliveira, Jorge Oliveira, Jorge M.A. Oliveira, Oliveira, Jorge, Oliveira, Jorge M A, Oliveira, Jorge MA, Oliveira, Jorge Miguel Ascenção

Observed institutions: Amgen (United States), Buck Institute for Research on Aging, Universidade do Porto, Instituto de Investigaciones Biomédicas Sols-Morreale, Wellcome Centre for Mitochondrial Research, Rede de Química e Tecnologia, LAQV Requimte, Unidade em Ciências Biomoleculares Aplicadas, University College London, Universidad Autónoma de Madrid, Newcastle University

ORCID: 0000-0002-6040-5355

Observed ORCID: 0000-0002-6040-5355

OpenAlex ID: A5071430258

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

2021 · Daniel J. Klionsky, Amal Kamal Abdel-Aziz, et al. · Autophagy · 2,608

PDF

Adenosine A2AReceptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway

2009 · Paula M. Canas, Lisiane O. Porciúncula, et al. · Journal of Neuroscience · 357

PDF

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

· Klionsky, Daniel J, Abdel-Aziz, Amal Kamal, et al. · Kölner Universitäts PublikationsServer (Universität zu Köln) · 178

Nature and cause of mitochondrial dysfunction in Huntington’s disease: focusing on huntingtin and the striatum

2010 · Jorge M. A. Oliveira · Journal of Neurochemistry · 163

PDF

Mitochondrial-Dependent Ca 2+ Handling in Huntington's Disease Striatal Cells: Effect of Histone Deacetylase Inhibitors

2006 · Jorge M. A. Oliveira, Sylvia Chen, et al. · Journal of Neuroscience · 139

PDF

Mitochondrial dysfunction in Huntington’s disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice

2007 · Jorge M. A. Oliveira, Mika B. Jekabsons, et al. · Journal of Neurochemistry · 137

Disruption of zebrafish (Danio rerio) embryonic development after full life-cycle parental exposure to low levels of ethinylestradiol

2009 · J. Soares, A.M. Coimbra, et al. · Aquatic Toxicology · 122

Mitochondrial dynamics and quality control in Huntington's disease

2015 · Pedro Guedes-Dias, Brígida R. Pinho, et al. · Neurobiology of Disease · 119

PDF

Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission

2009 · David M. Pereira, Federico Ferreres, et al. · Phytomedicine · 106

HDAC6 inhibition induces mitochondrial fusion, autophagic flux and reduces diffuse mutant huntingtin in striatal neurons

2015 · Pedro Guedes-Dias, João de Proença, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 103

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

2021 · Klionsky, Daniel J, Abdel-Aziz, Amal Kamal, et al. · Research at the University of Copenhagen (University of Copenhagen) · 101

The PERKs of mitochondria protection during stress: insights for PERK modulation in neurodegenerative and metabolic diseases

2022 · Liliana M. Almeida, Brígida R. Pinho, et al. · Biological reviews/Biological reviews of the Cambridge Philosophical Society · 100

How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria‐targeted drugs

2013 · Brígida R Pinho, Miguel M Santos, et al. · British Journal of Pharmacology · 97

PDF

Targeting the proteostasis network in Huntington’s disease

2018 · Tânia R. Soares, Sara D. Reis, et al. · Ageing Research Reviews · 90

PDF

Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson’s disease

2015 · Brígida R. Pinho, Sara D. Reis, et al. · Pharmacological Research · 84

PDF

Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency

2013 · Abdulraheem Almalki, Charlotte L. Alston, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 76

REXO2 Is an Oligoribonuclease Active in Human Mitochondria

2013 · Francesco Bruni, Pasqua Gramegna, et al. · PLoS ONE · 64

PDF

Lysine deacetylases and mitochondrial dynamics in neurodegeneration

2013 · Pedro Guedes-Dias, Jorge M.A. Oliveira · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 61

PDF

Pro‐oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes

2011 · Daniel José Barbosa, João Paulo Capela, et al. · British Journal of Pharmacology · 60

PDF

Simple and reproducible HPLC–DAD–ESI-MS/MS analysis of alkaloids in Catharanthus roseus roots

2009 · Federico Ferreres, David M. Pereira, et al. · Journal of Pharmaceutical and Biomedical Analysis · 56

Metabolic profiling and biological capacity of Pieris brassicae fed with kale (Brassica oleracea L. var. acephala)

2009 · Federico Ferreres, Fátima Fernandes, et al. · Food and Chemical Toxicology · 56

The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice

2019 · Brígida R. Pinho, Ana I. Duarte, et al. · Free Radical Biology and Medicine · 53

PDF

Mitochondrial superoxide generation induces a parkinsonian phenotype in zebrafish and huntingtin aggregation in human cells

2018 · Brígida R. Pinho, Sara D. Reis, et al. · Free Radical Biology and Medicine · 49

PDF

In Situ Mitochondrial Ca2+ Buffering Differences of Intact Neurons and Astrocytes from Cortex and Striatum

2008 · Jorge M.A. Oliveira, Jorge Gonçalves · Journal of Biological Chemistry · 45

PDF

Mitochondrial bioenergetics and dynamics in Huntington’s disease: tripartite synapses and selective striatal degeneration

2010 · Jorge M. A. Oliveira · Journal of Bioenergetics and Biomembranes · 44

Works count: 76

Citation count: 5,458

H-index: 28

I10-index: 42